Skip to main content

Closed

GSK: GSK plc Stock Analysis | finqOS

Healthcare · Drug Manufacturers - General

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+3.5% / yr

Operating margin24.1%

ROIC16.0%

Financially safe

Strong

Debt / equity1.03×

Interest coverage11.4×

Current ratio0.82×

Valuation

Unrated

P/E ratio16.2×

Dividend yield3.5%

GSK plc

GSKNew York Stock Exchange·USD·Closed

GSK plc

GSKNew York Stock Exchange·USD·Closed

$51.69

−0.73%

$51.69

−$0.38 (0.73%)

52W Range

60thpctl

Volume

1.00×avg

Mkt Cap

103.56BUSD

P/E

16.2TTM

Div Yield

3.45%ann

52W Range

60thpctl

Volume

1.00×avg

Market Cap

103.56BUSD

P/E Ratio

16.2TTM

Div Yield

3.45%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings